Effects on quality of life, anti-cancer responses, breast conserving surgery and survival with neoadjuvant docetaxel: a randomised study of sequential weekly versus three-weekly docetaxel following neoadjuvant doxorubicin and cyclophosphamide in women with primary breast cancer

Effects on quality of life, anti-cancer responses, breast conserving surgery and survival with neoadjuvant docetaxel: a randomised study of sequential weekly versus three-weekly docetaxel following neoadjuvant doxorubicin and cyclophosphamide in women with primary breast cancer

<p>Abstract</p> <p>Background</p> <p>Weekly docetaxel has occasionally been used in the neoadjuvant to downstage breast cancer to reduce toxicity and possibly enhance quality of life. However, no studies have compared the standard three weekly regimen to the weekly regi...

Full description

Bibliographic Details
Main Authors: Wiseman Janice, Samphao Srila, Beer Jeanette, Cowley Ged, El-Sheemy Mohamed, Walker Mary B, Vassanasiri Wichai, Aloysius Mark M, Eremin Jennifer M, Walker Leslie G, Jibril Jibril A, Valerio David, Clarke David J, Kamal Mujahid, Thorpe Gerald W, Baria Karin, Eremin Oleg
Format: Article
Language:English
Published: BMC 2011-05-01
Series:BMC Cancer
Subjects:
Breast cancer
Docetaxel
Neoadjuvant therapy
Quality of life
Online Access:http://www.biomedcentral.com/1471-2407/11/179

Internet

http://www.biomedcentral.com/1471-2407/11/179

Similar Items